Welcome to ChinaSort! Hotline: +86 28-60192838
Register Login Custom DepositUp to 10% cashback
Current Location: Molecular > Proteins > Co-IP
Project Introduction
Project Cases
Sample Requirements
FAQ
Technical Consultant

One-on-one consultation

Scan QR code to consult

Contact: +86 15884474332

Our Advantages
  • Professional & Reliable · PhD Expert Team
  • Credit Payment · Test First, Pay Later
  • High Cost-effectiveness · Quality & Affordable
  • Earn Points · Exchange for Rewards
  • Easy Reimbursement · Official Contract & Invoice
  • Reports Available · Apply Now
98% Satisfaction
Co-IP
8340 times
Bookings:
Average 7 working days
Service Period:
Project Introduction

 免疫共沉淀(Co-Immunoprecipitation) is以antigenantibody之间of专一性作用for基础用于确定两种proteinin完整cell内生理性相互作用ofhave效方法. 当cellin非变形条件下被裂解时, 完整cell内存in许多protein-protein间of相互作用被保留了下来. such as果用预先固化inagarose beads上ofproteinAofantibody免疫沉淀Aprotein, 那么withAproteinin体内结合ofproteinB也能一起沉淀下来, 再throughprotein变性分离, 对Bprotein进行detect, 以证实两者存in相互作用. 这种方法常用于determine两种目标proteinis否in体内结合, 也可用于确定一种特定proteinof新of作用搭档.

image.png

Project Cases

0dba28a5-a0c8-47a8-b62a-0e92425dd4b7 (1).jpg

Sample Requirements

1.  IP级别ofantibody; needresearchofprotein互作信息 (protein名称, 大小, 种属etc.)

2.实验样本: tissue样品>200mg, cell样品>2 x 10, protein样品大于2ml.


FAQ

    免疫共沉淀 (Co-IP) 实验中可能会遇到多种常见Question, 以下is一些常见ofQuestion及其可能of原因and解决方案:

    1, 高背景:

    可能原因: 非Specificityprotein结合, 转移膜上of非Specificity吸附etc..

    解决方案: in无Serumculture液中裂解cell以减少非Specificityprotein结合; note实验操作, 戴手套, 用镊子夹取, 不接触转移膜转移面etc.以避免非Specificity吸附.

    2, 实验失败:

    可能原因: 样品被proteinenzyme降解, antibody浓度太低或亲and力低, IPantibody未withagarose珠子结合etc..

    解决方案: in裂解样品中加入proteinenzyme抑制剂, note冰上操作, 避免反复冻融; 调整antibody浓度, 必要时设立浓度梯度, 摸索most佳浓度; 选用合适ofagarose珠子, 正确store防止变质或干燥.

    3, antibody选择:

    选择Specificity好ofantibody, can考虑using单抗.

    4, 未detect到互作protein或信号太弱:

    可能原因: 裂解液中去垢剂浓度过高或配方太强烈, proteinandprotein之间of相互作用太弱或不stableetc..

    解决方案: optimize裂解液配方, 降低去垢剂浓度; 尝试using不同ofcell或tissue裂解条件; 确保样品新鲜, 并加入proteinenzyme/磷酸enzyme抑制剂.

    5, Co-IPvalidate结果with其他validate方式不一致:

    可能原因: Co-IP中存in中间protein参with互作, 而其他validate方式无法detect到这种互作.

    解决方案: 综合考虑多种validate方式of结果, 结合其他实验数据进行analyze.

    6, 选择合适ofInputcontroland同型control:

    using实验usingofcell裂解液作forInputcontrol, 同型controlcan选择with实验antibody相同种属但Specificity不同ofantibody.

    7, 互作validate一定要usingWestern Blot吗?

    可见protein只能判断protein大小, 不能确定is否for目ofprotein, 因此usuallyneedWestern Blot进行confirm.

    8, Inputof带型不够亮:

    解决方案: can尝试瞬转过表达process.

    9, antibody浓度and加样量:

    usuallyneed进行optimize, 摸索most佳antibody浓度and加样量.

    10, 避免假阳性:

    选择Specificityantibodyis关键, Specificityantibodycan排除非Specificity结合进而排除假阳性.


 
Feedback Business Contact Inquiry Top